clear cell sarcoma of the kidney
Showing 51 - 75 of >10,000
Genetic Testing, Breast Cancer, Ovarian Cancer Trial in Boston (Video Education, Genetic Counseling)
Recruiting
- Genetic Testing
- +8 more
- Video Education
- Genetic Counseling
-
Boston, MassachusettsDana Farber Cancer Institute
Oct 31, 2022
Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory
Active, not recruiting
- Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
- +5 more
- Crizotinib (PF-02341066)
-
Brussels, Belgium
- +24 more
May 9, 2022
Advanced Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Duarte (Clostridium
Active, not recruiting
- Advanced Renal Cell Carcinoma
- +5 more
- Clostridium butyricum CBM 588 Probiotic Strain
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Renal Cell Carcinoma, Clear Cell, Somatic Trial in Melbourne (drug, radiation, procedure)
Not yet recruiting
- Renal Cell Carcinoma, Clear Cell, Somatic
- Pembrolizumab
- +2 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Oct 4, 2021
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Rochester, Madison (CCI-779,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
-
Rochester, Minnesota
- +1 more
Jan 12, 2022
Kidney Cancer Trial in Boston, Houston, Salt Lake City (Everolimus, Sunitinib)
Terminated
- Kidney Cancer
-
Boston, Massachusetts
- +3 more
Apr 26, 2021
Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Anti-OX40 Antibody PF-04518600
- +3 more
-
Los Angeles, California
- +9 more
Aug 5, 2022
IMaging PAtients for Cancer Drug selecTion - Renal Cell
Completed
- Clear-cell Metastatic Renal Cell Carcinoma
- Kidney Neoplasms
- Molecular imaging
-
Amsterdam, Netherlands
- +2 more
Dec 6, 2021
Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer Trial in New Brunswick (drug, other, procedure)
Terminated
- Clear Cell Renal Cell Carcinoma
- Stage I Renal Cell Cancer
- Enzalutamide
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Sep 14, 2021
Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder
Active, not recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +35 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +7 more
Jan 3, 2023
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Study of Kidney Tumors in Younger Patients
Recruiting
- Adult Cystic Nephroma
- +24 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +247 more
Sep 2, 2022
Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los
Recruiting
- Clear Cell Papillary Renal Neoplasm
- +10 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 25, 2021
Prostate Cancer, Bladder Cancer, Kidney Cancer Trial in New Brunswick (Body Mind Training (BMT), Body Training (BT):, Usual Care
Recruiting
- Prostate Cancer
- +8 more
- Body Mind Training (BMT)
- +2 more
-
New Brunswick, New JerseyRutgers University
Apr 28, 2022
Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)
Active, not recruiting
- Sarcoma
- +10 more
- Hypofractionated radiotherapy
- Hyperthermia
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 27, 2021
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Los Angeles
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- AdGMCAIX-transduced autologous dendritic cells
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Jul 28, 2021
Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,
Recruiting
- Malignant Digestive System Neoplasm
- +12 more
- Computed Tomography
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Metastatic Renal Cell Carcinoma, Kidney Tumor, Urologic Tumors Trial in Herlev (Medication (A specification is listed under each
Recruiting
- Metastatic Renal Cell Carcinoma
- +3 more
- Medication (A specification is listed under each arm)
- Patient reported outcomes measurement
-
Herlev, DenmarkDepartment of Oncology, Herlev and Gentofte Hospital
Nov 19, 2020
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,
Recruiting
- Advanced Renal Cell Carcinoma
- +8 more
- Cabozantinib S-malate
- +3 more
-
Birmingham, Alabama
- +35 more
Jan 24, 2023
Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)
Completed
- Head and Neck Squamous Cell Carcinoma
- +10 more
- Durvalumab
- +2 more
-
Atlanta, Georgia
- +6 more
Mar 1, 2022
Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)
Not yet recruiting
- Renal Cell Carcinoma
- Pucotenlimab Combined With Lenvatinib
-
Guangzhou, Other (Non U.s.), ChinaSun Yat-sen University Cancer Center
Nov 10, 2023
Clear Cell Metastatic Renal Cell Carcinoma Trial in France (Nivolumab, Ipilimumab, Pazopanib)
Completed
- Clear Cell Metastatic Renal Cell Carcinoma
- Nivolumab
- +3 more
-
Bordeaux, France
- +15 more
Apr 22, 2021
Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor Trial in Memphis (drug, biological, device)
Completed
- Ewing Sarcoma
- +12 more
- alemtuzumab
- +6 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 14, 2020